Which liver enzymes are implicated in tigecycline-related liver effects?
Tigecycline is cleared in large part through hepatic mechanisms, and its exposure and breakdown are influenced by liver drug-metabolizing enzymes. However, the specific enzymes that mediate tigecycline’s impact on liver function (for example, the enzymes responsible for causing liver test elevations or hepatotoxicity) are not clearly identified in the information provided here.
Does tigecycline meaningfully involve specific cytochrome P450 enzymes?
The exact cytochrome P450 (CYP) enzymes (or other hepatic enzymes such as UGTs or transporters) responsible for tigecycline-mediated liver enzyme abnormalities are not specified in the provided information.
Are any enzymes known to drive tigecycline metabolism?
The provided information does not list the metabolic enzymes responsible for tigecycline metabolism in the liver, so it also does not support naming which enzymes mediate its effect on liver function.
What you’d need to answer this precisely
To state which enzymes mediate tigecycline’s impact on liver function, you would need a source that explicitly links tigecycline to:
- the specific hepatic enzymes involved in its hepatic clearance/metabolism, and/or
- the mechanistic pathway for liver injury (for example, a hepatotoxic metabolite formed by a named enzyme), and/or
- identified drug–drug interaction data tied to particular enzymes.
Can you share what source or label text you’re using?
If you paste the relevant excerpt (e.g., from the prescribing information, a safety review, or a study) or share which document you’re referring to, I can extract the exact enzyme names and map them to the liver-function effect described.